SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-019994
Filing Date
2017-08-09
Accepted
2017-08-09 21:45:44
Documents
2
Period of Report
2017-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1639
2 EX-24 DOCUMENT attachment1.htm EX-24 2453
  Complete submission text file 0000899243-17-019994.txt   5534
Mailing Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615
Business Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Issuer) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Sullivan William A. (Reporting) CIK: 0001531562 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36370 | Film No.: 171019520